Eurofins Scientific SE
ERF: XPAR (FRA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| S$ | LOCK|cY>T | LOCK|JqG%p^F |
Eurofins Earnings: Hub-and-Spoke Network Investments Deliver Good Results; Raise Fair Value by 7%
Eurofins Scientific reported 3.7% organic sales growth during 2025, in line with PitchBook consensus, while growth accelerated to 4.7% in the fourth quarter. Adjusted EBITDA margin expanded to 22.5% from 22.3%.
